<DOC>
	<DOCNO>NCT02675205</DOCNO>
	<brief_summary>Part interventional neuroradiology procedure treatment select cerebral aneurysm base stenting . To reduce thromboembolic event , dual antiplatelet therapy ( APT ) combine aspirin clopidogrel propose close monitoring , since 1/3 patient low responder due variation biological response clopidogrel . Ticagrelor use team never evaluate randomize control trial . It could option APT due reproducible response less interindividual variability reduce monitoring . The aim study demonstrate interest ticagrelor dual APT platelet inhibition , patient undergo neurovascular stenting cerebral aneurysm .</brief_summary>
	<brief_title>Ticagrelor v Clopidogrel Platelet Inhibition Stenting Cerebral Aneurysm</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Intracranial Aneurysm</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>unruptured cerebral aneurysm elective endovascular treatment stenting require dual antiplatelet therapy require</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>